Flowflex COVID-19 Antigen Rapid Test (ART) - For self-testing

The Flowflex SARS-CoV-2 Antigen Rapid Test is authorised for use in Singapore by the Health Science Authority (HSA) under the Pandemic Special Access Route (PSAR). The test does not require skilled professionals or equipment to interpret the test results. Suitable for home and office use.

• Self-Testing Approval by HSA
• Pre-market approval by HSA
• CE Mark for self-testing
• FDA-EUA Approval